Evermay Wealth Management LLC Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Evermay Wealth Management LLC boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 298.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,440 shares of the medical device company’s stock after purchasing an additional 1,079 shares during the period. Evermay Wealth Management LLC’s holdings in Cooper Companies were worth $146,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of COO. SG Americas Securities LLC lifted its stake in Cooper Companies by 220.9% in the fourth quarter. SG Americas Securities LLC now owns 4,326 shares of the medical device company’s stock valued at $1,637,000 after purchasing an additional 2,978 shares during the last quarter. Raymond James & Associates lifted its position in shares of Cooper Companies by 2.3% during the fourth quarter. Raymond James & Associates now owns 143,961 shares of the medical device company’s stock worth $54,481,000 after acquiring an additional 3,298 shares in the last quarter. Portside Wealth Group LLC lifted its position in shares of Cooper Companies by 4.7% during the fourth quarter. Portside Wealth Group LLC now owns 2,432 shares of the medical device company’s stock worth $920,000 after acquiring an additional 110 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Cooper Companies by 207.4% during the fourth quarter. Assenagon Asset Management S.A. now owns 42,493 shares of the medical device company’s stock worth $16,081,000 after acquiring an additional 28,669 shares in the last quarter. Finally, Altfest L J & Co. Inc. lifted its position in shares of Cooper Companies by 22.5% during the fourth quarter. Altfest L J & Co. Inc. now owns 1,257 shares of the medical device company’s stock worth $476,000 after acquiring an additional 231 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Citigroup increased their target price on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Robert W. Baird upped their price target on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a report on Friday, May 31st. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price target on shares of Cooper Companies in a report on Wednesday, July 3rd. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $111.78.

Cooper Companies Price Performance

COO traded up $0.69 during trading on Thursday, reaching $92.68. The stock had a trading volume of 1,231,079 shares, compared to its average volume of 1,130,656. The stock has a market cap of $18.45 billion, a PE ratio of 54.44, a PEG ratio of 2.25 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $104.07. The business has a 50-day moving average of $91.39 and a 200-day moving average of $94.28.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. The business had revenue of $942.60 million for the quarter, compared to analysts’ expectations of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 earnings per share. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.